Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028

Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antipsychotics
1.3.3 Antidepressants
1.3.4 Antianxiety (Anxiolyitcs)
1.3.5 Anti-Seizure Medications
1.3.6 Stimulants
1.3.7 Cognitive Disorders And Dementia
1.3.8 Sleep Disorder Treatments
1.3.9 Substance Abuse Treatments
1.3.10 Hypnosis And Tranquilizers
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Treating Mental Disorders Market Perspective (2017-2028)
2.2 Drugs for Treating Mental Disorders Growth Trends by Region
2.2.1 Drugs for Treating Mental Disorders Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Treating Mental Disorders Market Dynamics
2.3.1 Drugs for Treating Mental Disorders Industry Trends
2.3.2 Drugs for Treating Mental Disorders Market Drivers
2.3.3 Drugs for Treating Mental Disorders Market Challenges
2.3.4 Drugs for Treating Mental Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Treating Mental Disorders Players by Revenue
3.1.1 Global Top Drugs for Treating Mental Disorders Players by Revenue (2017-2022)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
3.4 Global Drugs for Treating Mental Disorders Market Concentration Ratio
3.4.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Treating Mental Disorders Revenue in 2021
3.5 Drugs for Treating Mental Disorders Key Players Head office and Area Served
3.6 Key Players Drugs for Treating Mental Disorders Product Solution and Service
3.7 Date of Enter into Drugs for Treating Mental Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Treating Mental Disorders Breakdown Data by Type
4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028)
5 Drugs for Treating Mental Disorders Breakdown Data by Application
5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Treating Mental Disorders Market Size (2017-2028)
6.2 North America Drugs for Treating Mental Disorders Market Size by Type
6.2.1 North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
6.2.2 North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
6.2.3 North America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
6.3 North America Drugs for Treating Mental Disorders Market Size by Application
6.3.1 North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
6.3.2 North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
6.3.3 North America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
6.4 North America Drugs for Treating Mental Disorders Market Size by Country
6.4.1 North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
6.4.2 North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Treating Mental Disorders Market Size (2017-2028)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type
7.2.1 Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application
7.3.1 Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
7.4 Europe Drugs for Treating Mental Disorders Market Size by Country
7.4.1 Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type
8.2.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application
8.3.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region
8.4.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Treating Mental Disorders Market Size (2017-2028)
9.2 Latin America Drugs for Treating Mental Disorders Market Size by Type
9.2.1 Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
9.3 Latin America Drugs for Treating Mental Disorders Market Size by Application
9.3.1 Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
9.4 Latin America Drugs for Treating Mental Disorders Market Size by Country
9.4.1 Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type
10.2.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application
10.3.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country
10.4.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.1.5 Johnson and Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.7.5 Teva Pharmaceutical Recent Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.8.5 Dr. Reddy's Laboratories Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Details
11.9.2 Apotex Inc. Business Overview
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.9.5 Apotex Inc. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Details
11.11.2 Par Pharmaceutical Business Overview
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.11.5 Par Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Details
11.12.2 Aurobindo Pharma Business Overview
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.12.5 Aurobindo Pharma Recent Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Details
11.13.2 Torrent Pharmaceuticals Business Overview
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.13.5 Torrent Pharmaceuticals Recent Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Details
11.14.2 Jubilant Lifesciences Business Overview
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.14.5 Jubilant Lifesciences Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Details
11.16.2 Sandoz (Novartis) Business Overview
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.16.5 Sandoz (Novartis) Recent Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Details
11.17.2 Hansoh Pharmaceutical Business Overview
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.17.5 Hansoh Pharmaceutical Recent Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Details
11.18.2 WATSON Pharmaceuticals Business Overview
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.18.5 WATSON Pharmaceuticals Recent Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Details
11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.19.5 Zhejiang Langhua Pharmaceuticals Recent Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Details
11.20.2 Forest Laboratories Business Overview
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.20.5 Forest Laboratories Recent Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Details
11.21.2 H.Lundbeck A/S Business Overview
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.21.5 H.Lundbeck A/S Recent Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Details
11.22.2 Amneal Pharmaceuticals Business Overview
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.22.5 Amneal Pharmaceuticals Recent Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Details
11.23.2 Hetero Drugs Business Overview
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.23.5 Hetero Drugs Recent Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Details
11.24.2 Macleods Pharmaceuticals Business Overview
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.24.5 Macleods Pharmaceuticals Recent Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Details
11.25.2 Silarx Pharmacueticals Business Overview
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.25.5 Silarx Pharmacueticals Recent Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Details
11.26.2 Hikma Pharmaceuticals Business Overview
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.26.5 Hikma Pharmaceuticals Recent Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Details
11.27.2 Lupin Limited Business Overview
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.27.5 Lupin Limited Recent Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Details
11.28.2 Prinston Pharmaceutical Business Overview
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.28.5 Prinston Pharmaceutical Recent Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Details
11.29.2 STI Pharma Business Overview
11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.29.5 STI Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Injection
Table 5. Key Players of Solution
Table 6. Key Players of Other
Table 7. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Drugs for Treating Mental Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Drugs for Treating Mental Disorders Market Share by Region (2017-2022)
Table 11. Global Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Drugs for Treating Mental Disorders Market Share by Region (2023-2028)
Table 13. Drugs for Treating Mental Disorders Market Trends
Table 14. Drugs for Treating Mental Disorders Market Drivers
Table 15. Drugs for Treating Mental Disorders Market Challenges
Table 16. Drugs for Treating Mental Disorders Market Restraints
Table 17. Global Drugs for Treating Mental Disorders Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Drugs for Treating Mental Disorders Revenue Share by Players (2017-2022)
Table 19. Global Top Drugs for Treating Mental Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
Table 20. Ranking of Global Top Drugs for Treating Mental Disorders Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Drugs for Treating Mental Disorders Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drugs for Treating Mental Disorders Product Solution and Service
Table 24. Date of Enter into Drugs for Treating Mental Disorders Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2017-2022)
Table 28. Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2023-2028)
Table 30. Global Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Drugs for Treating Mental Disorders Revenue Share by Application (2017-2022)
Table 32. Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Drugs for Treating Mental Disorders Revenue Share by Application (2023-2028)
Table 34. North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 64. Johnson and Johnson Company Details
Table 65. Johnson and Johnson Business Overview
Table 66. Johnson and Johnson Drugs for Treating Mental Disorders Product
Table 67. Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 68. Johnson and Johnson Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Drugs for Treating Mental Disorders Product
Table 72. Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Drugs for Treating Mental Disorders Product
Table 77. Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 78. Eli Lilly Recent Developments
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Drugs for Treating Mental Disorders Product
Table 82. GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 83. GlaxoSmithKline Recent Developments
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Drugs for Treating Mental Disorders Product
Table 87. AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 88. AstraZeneca Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product
Table 92. Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Teva Pharmaceutical Company Details
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Drugs for Treating Mental Disorders Product
Table 97. Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 98. Teva Pharmaceutical Recent Developments
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Developments
Table 104. Apotex Inc. Company Details
Table 105. Apotex Inc. Business Overview
Table 106. Apotex Inc. Drugs for Treating Mental Disorders Product
Table 107. Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 108. Apotex Inc. Recent Developments
Table 109. Mylan Pharmaceuticals Company Details
Table 110. Mylan Pharmaceuticals Business Overview
Table 111. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 112. Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 113. Mylan Pharmaceuticals Recent Developments
Table 114. Par Pharmaceutical Company Details
Table 115. Par Pharmaceutical Business Overview
Table 116. Par Pharmaceutical Drugs for Treating Mental Disorders Product
Table 117. Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 118. Par Pharmaceutical Recent Developments
Table 119. Aurobindo Pharma Company Details
Table 120. Aurobindo Pharma Business Overview
Table 121. Aurobindo Pharma Drugs for Treating Mental Disorders Product
Table 122. Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 123. Aurobindo Pharma Recent Developments
Table 124. Torrent Pharmaceuticals Company Details
Table 125. Torrent Pharmaceuticals Business Overview
Table 126. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 127. Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 128. Torrent Pharmaceuticals Recent Developments
Table 129. Jubilant Lifesciences Company Details
Table 130. Jubilant Lifesciences Business Overview
Table 131. Jubilant Lifesciences Drugs for Treating Mental Disorders Product
Table 132. Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 133. Jubilant Lifesciences Recent Developments
Table 134. Sun Pharmaceutical Company Details
Table 135. Sun Pharmaceutical Business Overview
Table 136. Sun Pharmaceutical Drugs for Treating Mental Disorders Product
Table 137. Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 138. Sun Pharmaceutical Recent Developments
Table 139. Sandoz (Novartis) Company Details
Table 140. Sandoz (Novartis) Business Overview
Table 141. Sandoz (Novartis) Drugs for Treating Mental Disorders Product
Table 142. Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 143. Sandoz

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs